维普中文期刊产品整合服务
10篇 您的检索式:作者名="Angus K W"
    题名 作者 年代 出处 被引量
1Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial显示文摘Edward J Gane Stuart K Roberts Catherine AM Stedman Peter W Angus Brett Ritchie Rob Elston David Ipe Peter N Morcos Linda Baher Isabel Najera Tom Chu Uri Lopatin M Michelle Berrey William Bradford Mark Laughlin Nancy S Shulman Patrick F Smith 2010The Lancet2010,,9751:1
2Experimental cryptosporidiosis in laboratory mice 显示文摘SHERWOOD D ANGUS K W SNODGRASS D R 1982Infect Immun1982,38,2:1
3Experimental cryptosporidiosis in laboratory mice显示文摘Sherwood D Angus K W Snodgrass D R 1982Infect Immun1982,38,2:1
4Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver 显示文摘SARIN S K KUMAR A ANGUS P W 2005Hepatol Int2005,2,4:1
5Primary prophylaxis of gastroesophageal variceal bleeding:consensus recommendations of the Asian Pacific Association for the study of the liver显示文摘Sarin S K Kumar A Angus P W 2008Hepatol Int2008,2,4:1
6Experimental cryptosporidiosis in laboratory mice 显示文摘Sherwood D Angus K W Snodgrass D R 1982Infect Immun1982,38,2:1
7Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine 显示文摘Tenney DJ Levine SM Rose RE Walsh AW Weinheimer SP Discotto L Plym M Pokornowski K Yu CF Angus P Ayres A Bartholomeusz A Sievert W Thompson G Warner N Locarnini S Colonno ILl 2004Antimicrob Agents Chemother2004,48,9:1
8Experimental infection of lambs with Cryptosporidium isolated from a human patient with diarrhea显示文摘TZIPORI S ANGUS K W CAMPBELL I 1982Gut1982,23,:1
9Cryptosporidium: Evidence for a single-species genus 显示文摘Tzipori S Angus K W Campbell I 1980Infec Immun1980,30,3:1
10Clinical outcomes of patients with two small hepatocellular carcinomas显示文摘BACKGROUND Management of single small hepatocellular carcinoma(HCC)is straightforward with curative outcomes achieved by locoregional therapy or resection.Liver transplantation is often considered for multiple small or single large HCC.Management of two small HCC whether presenting synchronously or sequentially is less clear.AIM To define the outcomes of patients presenting with two small HCC.METHODS Retrospective review of HCC databases from multiple institutions of patients with either two synchronous or sequential HCC≤3 cm between January 2000 and March 2018.Primary outcomes were overall survival(OS)and transplant-free survival(TFS).RESULTS 104 patients were identified(male n=89).Median age was 63 years(interquartile range 58-67.75)and the most common aetiology of liver disease was hepatitis C(40.4%).59(56.7%)had synchronous HCC and 45(43.3%)had sequential.36 patients died(34.6%)and 25 were transplanted(24.0%).1,3 and 5-year OS was 93.0%,66.1% and 62.3% and 5-year post-transplant survival was 95.8%.1,3 and 5-year TFS was 82.1%,45.85% and 37.8%.When synchronous and sequential groups were compared,OS(1,3 and 5 year synchronous 91.3%,63.8%,61.1%,sequential 95.3%,69.5%,64.6%,P=0.41)was similar but TFS was higher in the sequential group(1,3 and 5 year synchronous 68.5%,37.3% and 29.7%,sequential 93.2%,56.6%,48.5%,P=0.02)though this difference did not remain during multivariate analysis.CONCLUSION TFS in patients presenting with two HCC≤3 cm is poor regardless of the timing of the second tumor.All patients presenting with two small HCC should be considered for transplantation.Anh Duy Pham Karl Vaz Zaid S Ardalan Marie Sinclair Ross Apostolov Sarah Gardner Ammar Majeed Gauri Mishra Ning Mao Kam Kurvi Patwala Numan Kutaiba Niranjan Arachchi Sally Bell Anouk T Dev John S Lubel Amanda J Nicoll Siddharth Sood William Kemp Stuart K Roberts Michael Fink Adam G Testro Peter W Angus Paul J Gow 2021World Journal of Hepatology2021,13,10:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费